To commemorate the NIH Common Fund 10 year anniversary, Dr. Collins co-authors an article with former NIH director Dr. Elias Zerhouni and NIH’s Dr. Elizabeth Wilder about why we must continue supporting innovative transdisciplinary science. Collins, F.S., Wilder, E.L., & Zerhouni, E. “NIH Roadmap/Common Fund at 10.” Sciencexpress 19 June 2014: 1-5.
In a Q&A with USA Today, Dr. Collins outlines what medical breakthroughs are on the horizon and how these discoveries will affect health in the future. USA Today. May 15, 2014.
In a Nature Comment, Dr. Collins and Dr. Janine Clayton outline NIH steps to address sex differences in preclinical research. Nature. 509, 282-283 (2014). Published online May 14, 2014.
Dr. Collins and NIH colleagues write an editorial in the Journal of American Medical Informatics Association on taking PCORnet from dream to reality. J Am Med Inform Assoc. Published online May 12, 2014.
In a Washington Post article on PCORI, Dr. Collins talks about how this new medical information repository gives scientists the ability to look at a large patient population with great speed and little cost. The Washington Post. April 15, 2014.
Dr. Collins pens an Op-Ed in The New York Times about the regular use of genetic testing in the near future, and the need to have clear protections and prohibitions around patient privacy and the misuse of test results. The New York Times. April 14, 2014.
Interviewed for Bloomberg News, Dr. Collins discusses researching new therapeutic uses for existing compounds in an effort to treat major diseases. Bloomberg News. April 11, 2014.
In a New York Times’ article and video, Dr. Collins acknowledges the importance of philanthropy in filling budget gaps, but emphasizes the ongoing need for public funding. The New York Times. March 15, 2014.
Dr. Collins has a conversation with AARP Bulletin about the BRAIN Initiative, his role leading the Human Genome Project, and more. AARP Bulletin. March 10, 2014.
In a Boston Globe article on cancer research budget gaps, Dr. Collins talks about the challenges in advancing the science with the current funding climate. Boston Globe. March 9, 2014.
In an interview with ASCO Post, Dr. Collins explains how NIH is focusing on working within its resource constraints to try to keep the engine of discovery moving forward. ASCO Post. March 1, 2014.
The Washington Post Editorial Board supports the Accelerating Medicines Partnership’s goal to find new biomarkers for Alzheimer’s, type 2 diabetes, rheumatoid arthritis and lupus. The Washington Post. February 8, 2014.
In the New York Times, Dr. Collins lauds the Accelerating Medicines Partnership as a unique collaboration which will work towards expediting the identification of new drug targets for three major disease areas. New York Times. February 4, 2014.
In a commentary for Nature, Drs. Collins and Tabak discuss the NIH’s initiatives to improve reproducibility, particularly in preclinical research. Collins, Francis S., and Tabak, Lawrence A. “NIH plans to enhance reproducibility.” Nature 505, 612-613 (27 January 2014).
This page last reviewed on
July 24, 2014